Aastrom Announces One-for-Eight Reverse Stock Split
The reverse stock split is intended to increase the per share trading price of Aastrom's common stock to satisfy the $ 1.00 minimum bid price requirement for continued listing on NASDAQ and to attract greater institutional ownership of the   05:38 Feb 9, 2010

Capstone Therapeutics to Present at 3rd Annual European Life Science CEO Forum
These risks include: delays in obtaining or inability to obtain FDA, institutional review board or other regulatory approvals of pre-clinical or clinical testing; unfavorable outcomes in our pre-clinical and clinical testing; the developmen   05:06 Feb 9, 2010

Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Progr
About Northera Northera ( droxidopa), the lead investigational agent in Chelsea Therapeutics' broad pipeline, is currently in Phase III clinical trials for the treatment of symptomatic neurogenic orthostatic hypotension ( NOH) in patients w   04:38 Feb 9, 2010

XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients
Previously, XOMA announced that the XOMA 052 Phase 2 program would include a Phase 2a extended safety trial in Type 2 diabetes patients for which interim results are expected in the fourth quarter of this year, a cardio-metabolic trial in T   04:06 Feb 9, 2010

Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
In addition to the milestone payments earned thus far, Nabi received a cash payment of $ 21.5 million when the transaction closed in November 2009 that included $ 20 million associated with the transaction close, $ 1 million associated with   06:26 Feb 8, 2010

Experienced Global Biotech Executive Joins biOasis as Executive Vice President
Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied   06:07 Feb 8, 2010

Nanosphere to Report Fourth Quarter and Year-End 2009 Results and Hold Investor Call Wednesday, Febr
NORTHBROOK, Ill., Feb. 8, 2010 ( GLOBE NEWSWIRE)- Nanosphere, Inc.,, which develops, manufactures, and markets advanced molecular diagnostics systems, will report its results for the fourth quarter and full year of 2009 after market close o   04:07 Feb 8, 2010

Nidec to Acquire SC WADO Co., Ltd. Through Nidec Electronics (Thailand) Co., Ltd.
( at Km 91-92), Borwin Sriracha, Cholburi, Thailand ( 3) Location: Pingthong, Cholburi, Thailand ( 4) Business Die-casting/ manufacturing of base plates for HDDs and hub manufacturing of spindle Description: motors ( 5) Employees: 320 ( 6)   16:06 Feb 7, 2010

Transition Therapeutics Announces Participation in 12th Annual BIO CEO & Investor Conference
For further information on Transition, visit www.transitiontherapeutics. com CONTACT: Transition Therapeutics Inc. Dr. Tony Cruz, Chief Executive Officer 416-260- 7770, x. 223 tcruz@ transitiontherapeutics. com Elie Farah, President & Chief   10:38 Feb 5, 2010

inVentiv Health to Announce Fourth Quarter and 2009 Full-Year Results and Conduct Conference Call on
About inVentiv Health inVentiv Health, Inc. is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communicatio   06:06 Feb 5, 2010

Liberty Analytics Co. Initiates Independent Research Coverage on Cardium Therapeutics
To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.libertyanalyticsco. com and click on the complimentary trial subscription button on our home page, or go directly to our registr   06:06 Feb 5, 2010

Biopharmaceutical Stock Alert for StemCells Inc. Issued by Beacon Equity
To read the entire report visit: http:// www.beaconequity. com/i/ STEM See what investors are saying about STEM at penny stock forum BeaconEquity. com is one of the industry's largest small-cap report providers.   03:52 Feb 5, 2010

Biopharmaceutical Stock Alert for Keryx Biopharmaceuticals Inc. Issued by InvestorSoup
To read the entire report visit: http:// www.investorsoup. com/lp/ KERX See what investors say about KERX at penny stock forum InvestorSoup. com is a small-cap research and investment commentary provider.   03:52 Feb 5, 2010

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter an
a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the fourth quarter and year ended December 31, 2009 before the U.S. financial markets open on Thursday, Feb   11:26 Feb 4, 2010

...

News Copyright © 2006 Interest!ALERT